Skip to main content
. 2022 Feb 20;42(2):171–180. [Article in Chinese] doi: 10.12122/j.issn.1673-4254.2022.02.02

表 1.

龙杞方治疗DKD KEGG通路富集分析

KEGG pathway enrichment analysis of Longqi Fang against DKD

ID Description p.adjust geneID Count
hsa04933 AGE-RAGE signaling pathway in diabetic complications 3.14E-05 CASP3/VEGFA/F3/ICAM1/CCL2/VCAM1/PRKCB/COL3A1 8
hsa05418 Fluid shear stress and atherosclerosis 3.14E-05 VEGFA/HMOX1/ICAM1/CCL2/VCAM1/PLAT/NQO1/KDR/HSP90AB1 9
hsa04020 Calcium signaling pathway 0.000253191 VEGFA/EGF/PRKCB/KDR/HRH1/HTR2B/FGF1/MYLK/EDNRA/FLT1 10
hsa04650 Natural killer cell mediated cytotoxicity 0.001273051 CASP3/IFNGR1/ICAM1/PRKCB/SYK/FYN/LCK 7
hsa04510 Focal adhesion 0.002172736 VEGFA/EGF/PRKCB/SPP1/KDR/FYN/MYLK/FLT1 8
hsa05207 Chemical carcinogenesis-receptor activation 0.00243623 VEGFA/EGF/RB1/MYC/PRKCB/AHR/NR1I3/HSP90AB1 8
hsa04066 HIF-1 signaling pathway 0.00243623 IFNGR1/VEGFA/EGF/HMOX1/PRKCB/FLT1 6
hsa04010 MAPK signaling pathway 0.003430192 CASP3/VEGFA/EGF/MYC/PRKCB/KDR/PLA2G4A/FGF1/FLT1 9
sa05219 Bladder cancer 0.003456589 VEGFA/EGF/RB1/MYC 4
hsa01521 EGFR tyrosine kinase inhibitor resistance 0.003588057 VEGFA/EGF/PRKCB/KDR/AXL 5
hsa05167 Kaposi sarcoma-associated herpesvirus infection 0.00549286 CASP3/IFNGR1/VEGFA/RB1/MYC/ICAM1/SYK 7
hsa04614 Renin-angiotensin system 0.007730096 MME/KLK1/CPA3 3
hsa04151 PI3K-Akt signaling pathway 0.008028541 VEGFA/EGF/MYC/SPP1/KDR/SYK/FGF1/FLT1/HSP90AB1 9
hsa05417 Lipid and atherosclerosis 0.008028541 CASP3/CASP1/HSPA5/ICAM1/CCL2/VCAM1/HSP90AB1 7
hsa04370 VEGF signaling pathway 0.008048184 VEGFA/PRKCB/KDR/PLA2G4A 4
hsa04064 NF-kappa B signaling pathway 0.008048184 ICAM1/VCAM1/PRKCB/SYK/LCK 5
hsa04014 Ras signaling pathway 0.010016525 VEGFA/EGF/PRKCB/KDR/PLA2G4A/FGF1/FLT1 7
hsa04668 TNF signaling pathway 0.010016525 CASP3/ICAM1/CCL2/VCAM1/IRF1 5
hsa05164 Influenza A 0.010155883 CASP3/CASP1/IFNGR1/ICAM1/CCL2/PRKCB 6
hsa04726 Serotonergic synapse 0.010155883 CASP3/PRKCB/ALOX5/PLA2G4A/HTR2B 5